ZYDUS Company Profile

✉ Email this page to a colleague

ZYDUS has three hundred and seventy-eight approved drugs.

There is one US patent protecting ZYDUS drugs. There are twenty-six tentative approvals on ZYDUS drugs.

There are four patent family members on ZYDUS drugs in four countries and nine hundred and sixty-five supplementary protection certificates in eighteen countries.

International Patents:	4
US Patents:	1
Tradenames:	306
Ingredients:	296
NDAs:	378
Patent Litigation for ZYDUS:	See patent lawsuits for ZYDUS

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms	NIFEDIPINE	nifedipine	TABLET, EXTENDED RELEASE;ORAL	210184-001	Jun 29, 2018	AB1	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zydus Pharms Usa	AZATHIOPRINE	azathioprine	TABLET;ORAL	077621-001	Mar 15, 2007	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zydus	VALBENAZINE TOSYLATE	valbenazine tosylate	CAPSULE;ORAL	216137-001	Aug 7, 2024	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zydus Pharms Usa	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET;ORAL	077064-002	Apr 18, 2005	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zydus Pharms	SIROLIMUS	sirolimus	TABLET;ORAL	201676-002	Feb 15, 2023	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zydus Pharms	LAMOTRIGINE	lamotrigine	TABLET, EXTENDED RELEASE;ORAL	207763-005	Apr 1, 2020	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zydus Pharms	CLOZAPINE	clozapine	TABLET;ORAL	209480-001	Dec 6, 2017		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
India	651MU2014	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2015128877	⤷ Sign Up
South Africa	201606075	⤷ Sign Up
Philippines	12016501686	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1429780	13C0012	France	⤷ Sign Up	PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
1411900	18/2011	Austria	⤷ Sign Up	PRODUCT NAME: NAPROXEN UND ESOMEPRAZOL SOWIE DEREN PHARMAZEUTISCH ANNEHMBARE SALZE; NAT. REGISTRATION NO/DATE: 1-29937 20110105; FIRST REGISTRATION: GB PL 17901/0263-0001 20101105
0788511	08C0028	France	⤷ Sign Up	PRODUCT NAME: MICAFUNGINE; REGISTRATION NO/DATE: EU/1/08/448/001-002 20080425
1467728	C01467728/01	Switzerland	⤷ Sign Up	PRODUCT NAME: SACUBRITIL UND VALSARTAN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 65673 17.09.2015
1436271	2014C/036	Belgium	⤷ Sign Up	PRODUCT NAME: VORTIOXETINE; AUTHORISATION NUMBER AND DATE: EU/1/13/891 20131220
0480717	98C0025	Belgium	⤷ Sign Up	PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215
1453521	300814	Netherlands	⤷ Sign Up	PRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.